On February 3, 2016, Pacgen Life Science Corporation closed the transaction. The transaction included participation from the members of company's board of directors who invested CAD 248,000. The securities issued are subject to a hold period expiring on June 3, 2016.

TSX Venture Exchange has accepted for filing documentation with respect to the transaction. The transaction included participation from a total of four placees, including Southern Gold Resources Ltd for 2,000,000 shares, Christina Yip; Chief Financial Officer of the company for 1,300,000 shares, and Chung Yu Wang; Interim Chief Executive Officer of the company for 833,334 shares.